Stocks and Investing Stocks and Investing
Tue, October 31, 2023
Mon, October 30, 2023

Joseph Pantginis Maintained (VYNE) at Strong Buy with Decreased Target to $5.75 on, Oct 30th, 2023


Published on 2024-10-28 07:11:05 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "VYNE Therapeutics Inc." (VYNE) at Strong Buy with Decreased Target from $28 to $5.75 on, Oct 30th, 2023.

Joseph, nor any peers, have made any analyst calls on VYNE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources